0001209191-21-006098.txt : 20210129 0001209191-21-006098.hdr.sgml : 20210129 20210129163012 ACCESSION NUMBER: 0001209191-21-006098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210128 FILED AS OF DATE: 20210129 DATE AS OF CHANGE: 20210129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dentzer James E CENTRAL INDEX KEY: 0001400977 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30347 FILM NUMBER: 21571594 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 6 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CURIS INC CENTRAL INDEX KEY: 0001108205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043505116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING C, SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-503-6500 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING C, SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-28 0 0001108205 CURIS INC CRIS 0001400977 Dentzer James E C/O CURIS, INC. 128 SPRING STREET BUILDING C SUITE 500 LEXINGTON MA 02421 1 1 0 0 President & CEO Employee stock option (right to buy) 9.14 2021-01-28 4 A 0 330000 0.00 A 2031-01-27 Common stock 330000 330000 D The option grant described in this Form 4 filing vests as to 25% of the original shares on January 28, 2022 and as to an additional 6.25% of the original shares each successive quarter and until January 28, 2025. /s/ William Steinkrauss, Attorney-in-fact 2021-01-29